In other words, if the method of sampling does not accurately reflect the heterogeneity of PD-L1 expression within a given tumor or between different tumors, then the accuracy and the predictive value of PD-L1 is likely to be less representative of the response to therapy. This evidence concerns the gene CD274 and neoplasm.